Hansa’s Idefirix shows potential as pre-treatment to Elevidys
Hansa Biosciences will discuss next steps for the therapy with Sarepta Biosciences.
05 August 2025
05 August 2025
Hansa Biosciences will discuss next steps for the therapy with Sarepta Biosciences.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.